Abstract
Birt–Hogg–Dubé syndrome (BHD) is an autosomal dominant condition due to germline FLCN (folliculin) mutations, characterized by skin fibrofolliculomas, lung cysts, pneumothorax and renal cancer. We identified a de novo FLCN mutation, c.499C>T (p.Gln167X), in a patient who presented with spontaneous pneumothorax. Subsequently, typical skin features and asymptomatic renal cancer were diagnosed. Probably, de novo FLCN mutations are rare. However, they may be under-diagnosed if BHD is not considered in sporadic patients who present with one or more of the syndromic features. Genetic and immunohistochemical analysis of the renal tumour indicated features compatible with a tumour suppressor role of FLCN. The finding that mutant FLCN was expressed in the tumour might indicate residual functionality of mutant FLCN, a notion which will be explored in future studies.
Similar content being viewed by others
References
Birt AR, Hogg GR, Dubé WJ (1977) Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113:1674–1677
Roth JS, Rabinowitz AD, Benson M (1993) Bilateral renal cell carcinoma in the Birt–Hogg–Dubé syndrome. J Am Acad Dermatol 29:1055–1056
Zbar B, Alvord WG, Glenn G et al (2002) Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt–Hogg–Dubé syndrome. Cancer Epidemiol Biomark Prev 11:393–400
Nickerson ML, Warren MB, Toro JR et al (2002) Mutations in a novel gene lead to kidney tumours, lung wall defects, and benign tumours of the hair follicle in patients with the Birt–Hogg–Dubé syndrome. Cancer Cell 2:157–164
Graham RB, Nolasco M, Peterlin B et al (2005) Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults. Am J Respir Crit Care Med 172:39–44
Painter JN, Tapanainen HA, Somer M et al (2005) 4-bp deletion in the Birt–Hogg–Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am J Hum Genet 76:522–527
Woodward ER, Ricketts C, Killick P et al (2008) Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN. Clin Cancer Res 14:5925–5930
Schmidt LS, Nickerson ML, Warren MB et al (2005) Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt–Hogg–Dubé syndrome. Am J Hum Genet 76:1023–1033
Toro JR, Wei MH, Glenn GM et al (2008) BHD mutations, clinical and molecular genetic investigations of Birt–Hogg–Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 45:321–331
Benhammou JN, Vocke CD, Santani A et al (2011) Identification of intragenic deletions and duplication in the FLCN gene in Birt–Hogg–Dubé syndrome. Genes Chromosomes Cancer 50:466–477
Wei MH, Blake PW, Shevchenko J, Toro JR (2009) The folliculin mutation database: an online database of mutations associated with Birt–Hogg–Dubé syndrome. Hum Mutat 30:E880–E890
Lim DH, Rehal PK, Nahorski MS et al (2010) A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene. Hum Mutat 1:E1043–E1051
van Steensel MA, van Geel M, Badeloe S et al (2009) Molecular pathways involved in hair follicle tumor formation: all about mammalian target of rapamycin? Exp Dermatol 18:185–191
Hasumi Y, Baba M, Ajima R et al (2009) Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci USA 106:18722–18727
Nookala RK, Langemeyer L, Pacitto A et al (2012) Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer. Open Biol 2:120071
Menko FH, van Steensel MA, Giraud S et al (2009) European BHD Consortium. Birt–Hogg–Dubé syndrome: diagnosis and management. Lancet Oncol 10:1199–1206
Win AK, Jenkins MA, Buchanan DD et al (2011) Determining the frequency of de novo germline mutations in DNA mismatch repair genes. J Med Genet 48:530–534
Aretz S, Uhlhaas S, Caspari R (2004) Frequency and parental origin of de novo APC mutations in familial adenomatous poly-posis. Eur J Hum Genet 12:52–58
Preston RS, Phil A, Claessens T et al (2011) Absence of the Birt–Hogg–Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene 30:1159–1173
Leter EM, Koopmans AK, Gille JJ et al (2008) Birt–Hogg–Dubé syndrome: clinical and genetic studies of 20 families. J Invest Dermatol 128:45–49
Houweling AC, Gijezen LM, Jonker MA et al (2011) Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Br J Cancer 105:1912–1919
Noppen M (2010) Spontaneous pneumothorax: epidemiology, pathophysiology and cause. Eur Respir Rev 19:217–219
Grundy S, Bentley A, Tschopp J-M (2012) Primary spontaneous pneumothorax: a diffuse disease of the pleura. Respiration 83:185–189
Toro JR, Pautler SE, Stewart L et al (2007) Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt–Hogg–Dubé syndrome. Am J Respir Crit Care Med 175:1044–1053
Fröhlich BA, Zeitz C, Mátyás G et al (2008) Novel mutations in the folliculin gene associated with spontaneous pneumothorax. Eur Respir J 32:1316–1320
Kluger N, Giraud S, Coupier I et al (2010) Birt–Hogg–Dubé syndrome: clinical and genetic studies of 10 French families. Br J Dermatol 162:527–537
Butnor KJ, Guinee DG Jr (2006) Pleuropulmonary pathology in Birt–Hogg–Dubé syndrome. Am J Surg Pathol 30:395–399
Ayo DS, Aughenbaugh GL, Yi ES et al (2007) Cystic lung disease in Birt–Hogg–Dubé syndrome. Chest 132:679–684
Koga S, Furuya M, Takahashi Y et al (2009) Lung cysts in Birt–Hogg–Dubé syndrome: histopathological characteristics and aberrant sequence repeats. Pathol Int 59:720–728
Furuya M, Tanaka R, Koga S et al (2012) Pulmonary cysts of Birt–Hogg–Dubé syndrome: a clinicopathological and immunohistochemical study of 9 families. Am J Surg Pathol 36:589–600
Vocke CD, Yang Y, Pavlovich CP et al (2005) High frequency of somatic frameshift BHD gene mutations in Birt–Hogg–Dubé-associated renal tumors. J Natl Cancer Inst 97:931–935
Acknowledgments
MvS and BJC are supported by grants from the Dutch Cancer Society KWF (UM2009-4352), the Association for International Cancer Research AICR (11-0687) and the Annadal Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Menko, F.H., Johannesma, P.C., van Moorselaar, R.J.A. et al. A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation. Familial Cancer 12, 373–379 (2013). https://doi.org/10.1007/s10689-012-9593-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-012-9593-8